Gary Tse-Gary

Tianjin Key Laboratory Of Ionic Molecular Function Of Cardiovascular Disease
Tianjin, 300211, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

C-reactive protein-to-albumin ratio as a novel prognostic biomarker for long-term mortality in pericarditis: a real-world study.

C-reactive protein-to-albumin ratio as a novel prognostic biomarker for long-term mortality in pericarditis: a real-world study.

Journal: BMC cardiovascular disorders

Published: November 18, 2025

Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study.

Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study.

Journal: Cardiovascular drugs and therapy

Published: January 03, 2024

Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis.

Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis.

Journal: Cardiovascular diabetology

Published: September 08, 2022

Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study.

Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: March 06, 2022

Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis.

Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis.

Journal: Cardio-oncology (London, England)

Published: August 19, 2021

Paediatric/young versus adult patients with long QT syndrome.

Paediatric/young versus adult patients with long QT syndrome.

Journal: Open heart

Published: March 31, 2021

Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study.

Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study.

Journal: Gut

Published: November 19, 2020

Development of a predictive risk model for all-cause mortality in patients with diabetes in Hong Kong.

Development of a predictive risk model for all-cause mortality in patients with diabetes in Hong Kong.

Journal: BMJ open diabetes research & care

Published: October 15, 2020

Identification of important risk factors for all-cause mortality of acquired long QT syndrome patients using random survival forests and non-negative matrix factorization.

Identification of important risk factors for all-cause mortality of acquired long QT syndrome patients using random survival forests and non-negative matrix factorization.

Journal: Heart rhythm

Published: July 10, 2020

Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.

Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.

Journal: Heart (British Cardiac Society)

Published: April 05, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026